Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Artrya Limited ( (AU:AYA) ) has issued an announcement.
Artrya Limited has announced the quotation of 437,856 ordinary fully paid securities on the ASX, effective June 20, 2025. This move is part of the company’s strategic efforts to enhance its market presence and operational capacity, potentially impacting its financial performance and stakeholder interests positively.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$2.21 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the healthcare industry, focusing on developing innovative medical technologies. The company is known for its advanced solutions in cardiac health, aiming to improve diagnostic accuracy and patient outcomes.
Average Trading Volume: 244,279
Technical Sentiment Signal: Buy
See more insights into AYA stock on TipRanks’ Stock Analysis page.